Privium Fund Management (Uk) LTD Protara Therapeutics, Inc. Transaction History

Privium Fund Management (Uk) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$1.96 - $4.14 $9,843 - $20,791	-5,022 Reduced 4.19%	114,708 $238,000
Q4 2022 Feb 09, 2023	BUY	$2.43 - $3.7 $205,893 - $313,501	84,730 Added 242.09%	119,730 $320,000
Q3 2022 Nov 01, 2022	BUY	$2.96 - $4.27 $103,600 - $149,449	35,000 New	35,000 $104,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $55.4M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Privium Fund Management (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Privium Fund Management (Uk) LTD with notifications on news.